SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis.
van Kempen ZLE, Stalman EW, Steenhuis M, Kummer LYL, van Dam KPJ, Wilbrink MF, Ten Brinke A, van Ham SM, Kuijpers T, Rispens T, Eftimov F, Wieske L, Killestein J; T2B! immunity against SARS-CoV-2 study group.
van Kempen ZLE, et al.
J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):280-283. doi: 10.1136/jnnp-2022-330100. Epub 2022 Dec 23.
J Neurol Neurosurg Psychiatry. 2023.
PMID: 36564175